Khirul Islam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Khirul Islam has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Sanjib Saha
Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa
8 shared publications - Jamil Ahmad Shilpi
Pharmacy Discipline, Khulna University, Khulna 9208, Bangladesh
6 shared publications Urpo Lamminmäki
Department of Life Technologies and FICAN West Cancer Research Center, Division of Biotechnology, University of Turku, Finland; InFLAMES Research Flagship Center, University of Turku, Finland
5 shared publications- Imran Mahmud
Affiliations Department of Life Technologies, Biotechnology Division, University of Turku, Turku, Finland, Department of Pharmacy, Khwaja Yunus Ali University, Sirajganj, Bangladesh
4 shared publications - Mustafizur Rahman
Khulna University
4 shared publications - Afjalus Siraj
Department of Pharmaceutical Sciences, College of Pharmacy, Ferris State University, Big Rapids, MI 49307, USA
3 shared publications
Latest Publications
- Open Access
- 4 June 2026
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 280, 117589
Glycovariant-based diagnosis of bladder cancer using urinary mucin 1 and carcinoembryonic antigen
- 4 June 2026
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 280, 117589
Open AccessGlycovariant-based diagnosis of bladder cancer using urinary mucin 1 and carcinoembryonic antigen
- Open Access
- 6 July 2025
- Published by Wiley in Journal of Extracellular Biology
- Vol. 4 (7)
High‐Sensitivity Detection of Urinary Extracellular Vesicles With Upconverting Nanoparticle‐Based Lateral Flow Immunoassay
Urinary extracellular vesicles (uEVs) are well‐known to express tetraspanin family membrane proteins abundantly on their surface. In this study, we aimed to develop an upconverting nanoparticle (UCNP)–based lateral flow immunoassay (UCNP‐LFIA) designed for the rapid and high‐sensitivity detection of CD63‐positive uEVs for direct urinalysis. The assay utilizes UCNPs reporter to detect low concentrations of EVs. Minimally processed uEV samples from bladder cancer (BlCa) (n = 62), benign prostatic hyperplasia (BPH) (n = 50) and healthy (n = 30) individuals were tested in sandwich UCNP‐LFIA format, capturing uEVs with the same anti‐CD63 antibody conjugated to UCNP and immobilized on the test zone. After 80 min, the strips were read with an upconversion luminescence reader device. This UCNP‐LFIA measured CD63‐positive EVs with high sensitivity, exhibiting a limit of detection (LoD) of 4 × 107 EVs/mL. The concentration of CD63‐positive EVs in BlCa patients showed a 2.3‐fold increase compared to benign conditions (p = 0.007), and a 16‐fold increase compared to healthy controls (p = 0.00001). The results demonstrate the potential of UCNP‐LFIA platform for sensitive and quantitative detection of uEVs, highlighting its promise as a tool for EV detection at point‐of‐care diagnostics.
- 6 July 2025
- Published by Wiley in Journal of Extracellular Biology
- Vol. 4 (7)
Open AccessHigh‐Sensitivity Detection of Urinary Extracellular Vesicles With Upconverting Nanoparticle‐Based Lateral Flow Immunoassay
Urinary extracellular vesicles (uEVs) are well‐known to express tetraspanin family membrane proteins abundantly on their surface. In this study, we aimed to develop an upconverting nanoparticle (UCNP)–based lateral flow immunoassay (UCNP‐LFIA) designed for the rapid and high‐sensitivity detection of CD63‐positive uEVs for direct urinalysis. The assay utilizes UCNPs reporter to detect low concentrations of EVs. Minimally processed uEV samples from bladder cancer (BlCa) (n = 62), benign prostatic hyperplasia (BPH) (n = 50) and healthy (n = 30) individuals were tested in sandwich UCNP‐LFIA format, capturing uEVs with the same anti‐CD63 antibody conjugated to UCNP and immobilized on the test zone. After 80 min, the strips were read with an upconversion luminescence reader device. This UCNP‐LFIA measured CD63‐positive EVs with high sensitivity, exhibiting a limit of detection (LoD) of 4 × 107 EVs/mL. The concentration of CD63‐positive EVs in BlCa patients showed a 2.3‐fold increase compared to benign conditions (p = 0.007), and a 16‐fold increase compared to healthy controls (p = 0.00001). The results demonstrate the potential of UCNP‐LFIA platform for sensitive and quantitative detection of uEVs, highlighting its promise as a tool for EV detection at point‐of‐care diagnostics.
- 9 April 2025
- Published by Taylor & Francis in Nanomedicine
- Vol. 20 (13) , 1521-1524
Designing nanoparticle-based bioaffinity assays for the detection of extracellular vesicles
- 9 April 2025
- Published by Taylor & Francis in Nanomedicine
- Vol. 20 (13) , 1521-1524
Designing nanoparticle-based bioaffinity assays for the detection of extracellular vesicles
- Open Access
- 29 September 2023
- Published by Springer Nature in Biomarker Research
- Vol. 11 (1) , 1-22
Lectins as potential tools for cancer biomarker discovery from extracellular vesicles
Extracellular vesicles (EVs) have considerable potential as diagnostic, prognostic, and therapeutic agents, in large part because molecular patterns on the EV surface betray the cell of origin and may also be used to “target” EVs to specific cells. Cancer is associated with alterations to cellular and EV glycosylation patterns, and the surface of EVs is enriched with glycan moieties. Glycoconjugates of EVs play versatile roles in cancer including modulating immune response, affecting tumor cell behavior and site of metastasis and as such, paving the way for the development of innovative diagnostic tools and novel therapies. Entities that recognize specific glycans, such as lectins, may thus be powerful tools to discover and detect novel cancer biomarkers. Indeed, the past decade has seen a constant increase in the number of published articles on lectin-based strategies for the detection of EV glycans. This review explores the roles of EV glycosylation in cancer and cancer-related applications. Furthermore, this review summarizes the potential of lectins and lectin-based methods for screening, targeting, separation, and possible identification of improved biomarkers from the surface of EVs.
- 29 September 2023
- Published by Springer Nature in Biomarker Research
- Vol. 11 (1) , 1-22
Open AccessLectins as potential tools for cancer biomarker discovery from extracellular vesicles
Extracellular vesicles (EVs) have considerable potential as diagnostic, prognostic, and therapeutic agents, in large part because molecular patterns on the EV surface betray the cell of origin and may also be used to “target” EVs to specific cells. Cancer is associated with alterations to cellular and EV glycosylation patterns, and the surface of EVs is enriched with glycan moieties. Glycoconjugates of EVs play versatile roles in cancer including modulating immune response, affecting tumor cell behavior and site of metastasis and as such, paving the way for the development of innovative diagnostic tools and novel therapies. Entities that recognize specific glycans, such as lectins, may thus be powerful tools to discover and detect novel cancer biomarkers. Indeed, the past decade has seen a constant increase in the number of published articles on lectin-based strategies for the detection of EV glycans. This review explores the roles of EV glycosylation in cancer and cancer-related applications. Furthermore, this review summarizes the potential of lectins and lectin-based methods for screening, targeting, separation, and possible identification of improved biomarkers from the surface of EVs.
- Open Access
- 1 September 2021
- Published by Elsevier in Analytical Biochemistry
- Vol. 628, 114283
Detection of bladder cancer with aberrantly fucosylated ITGA3
- 1 September 2021
- Published by Elsevier in Analytical Biochemistry
- Vol. 628, 114283
Open AccessDetection of bladder cancer with aberrantly fucosylated ITGA3
- Open Access
- 11 July 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-9
A Nanoparticle-Based Approach for the Detection of Extracellular Vesicles
The analysis of extracellular vesicles (EVs) typically requires tedious and time-consuming isolation process from bio-fluids. We developed a nanoparticle-based time resolved fluorescence immunoassay (NP-TRFIA) that uses biotinylated antibodies against the proteins of tetraspanin family and tumor-associated antigens for capturing EVs from urine samples and cell culture supernatants without the need for isolation. The captured-EVs were detected either with Eu3+-chelate or Eu3+-doped nanoparticle-based labels conjugated either to antibodies against the tetraspanins or lectins targeting the glycan moieties on EVs surface. The NP-TRFIA demonstrated specific capturing and detection of EVs by antibodies and lectins. Lectin-nanoparticle based assays showed 2–10 fold higher signal-to-background ratio compared with lectin-chelate assays. The nanoparticle assay concept allowed surface glycosylation profiling of the urine derived-EVs with lectins. It was also applied to establish an assay showing differential expression of tumor-associated proteins on more aggressive (higher ITGA3 on DU145- and PC3-EVs) compared to less aggressive (higher EpCAM on LNCaP-EVs) PCa- cell lines derived-EVs. This NP-TRFIA can be used as a simple tool for analysis and characterization of EVs in urine and cell culture supernatants. Such approach could be useful in identification of disease-specific markers on the surface of patient-derived urinary EVs.
- 11 July 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-9
Open AccessA Nanoparticle-Based Approach for the Detection of Extracellular Vesicles
The analysis of extracellular vesicles (EVs) typically requires tedious and time-consuming isolation process from bio-fluids. We developed a nanoparticle-based time resolved fluorescence immunoassay (NP-TRFIA) that uses biotinylated antibodies against the proteins of tetraspanin family and tumor-associated antigens for capturing EVs from urine samples and cell culture supernatants without the need for isolation. The captured-EVs were detected either with Eu3+-chelate or Eu3+-doped nanoparticle-based labels conjugated either to antibodies against the tetraspanins or lectins targeting the glycan moieties on EVs surface. The NP-TRFIA demonstrated specific capturing and detection of EVs by antibodies and lectins. Lectin-nanoparticle based assays showed 2–10 fold higher signal-to-background ratio compared with lectin-chelate assays. The nanoparticle assay concept allowed surface glycosylation profiling of the urine derived-EVs with lectins. It was also applied to establish an assay showing differential expression of tumor-associated proteins on more aggressive (higher ITGA3 on DU145- and PC3-EVs) compared to less aggressive (higher EpCAM on LNCaP-EVs) PCa- cell lines derived-EVs. This NP-TRFIA can be used as a simple tool for analysis and characterization of EVs in urine and cell culture supernatants. Such approach could be useful in identification of disease-specific markers on the surface of patient-derived urinary EVs.
- 22 June 2018
- Published by Walter de Gruyter GmbH in Journal of Complementary and Integrative Medicine
- Vol. 16 (1)
Ethnomedicinal, phytochemical and pharmacological profile of a mangrove plant Ceriops Decandra GriffDin Hou.
Ceriops decandra is a mangrove tree species, reputed for its folkloric uses in the treatment of gastrointestinal disorders, infection, snakebites, inflammation, and cancer. Different parts of the plant are rich with various phytoconstituents which include diterpenoids (ceriopsin A-G), triterpenoids (lupeol, α-amyrin, oleanolic acid, ursolic acid), and phenolics (catechin, procyanidins).These phytoconstituents and their derivatives could form a new basis for developing new drugs against various diseases. The objective of the present study is to compile the phytochemical, ethnobotanical, biological, and pharmacological significance of the plant to provide directions for future research to find out therapeutically active lead compounds for developing new drugs against diseases of current interest including diabetes, inflammation, and cancer.
- 22 June 2018
- Published by Walter de Gruyter GmbH in Journal of Complementary and Integrative Medicine
- Vol. 16 (1)
Ethnomedicinal, phytochemical and pharmacological profile of a mangrove plant Ceriops Decandra GriffDin Hou.
Ceriops decandra is a mangrove tree species, reputed for its folkloric uses in the treatment of gastrointestinal disorders, infection, snakebites, inflammation, and cancer. Different parts of the plant are rich with various phytoconstituents which include diterpenoids (ceriopsin A-G), triterpenoids (lupeol, α-amyrin, oleanolic acid, ursolic acid), and phenolics (catechin, procyanidins).These phytoconstituents and their derivatives could form a new basis for developing new drugs against various diseases. The objective of the present study is to compile the phytochemical, ethnobotanical, biological, and pharmacological significance of the plant to provide directions for future research to find out therapeutically active lead compounds for developing new drugs against diseases of current interest including diabetes, inflammation, and cancer.
- Open Access
- 30 June 2016
- Published by Maad Rayan Publishing Company in Advanced Pharmaceutical Bulletin
- Vol. 6 (2) , 275-283
Anti-Inflammatory and Antioxidant Activity of Acalypha hispida Leaf and Analysis of its Major Bioactive Polyphenols by HPLC
Anti-Inflammatory and Antioxidant Activity of Acalypha hispida Leaf and Analysis of its Major Bioactive Polyphenols by HPLC
- 30 June 2016
- Published by Maad Rayan Publishing Company in Advanced Pharmaceutical Bulletin
- Vol. 6 (2) , 275-283
Open AccessAnti-Inflammatory and Antioxidant Activity of Acalypha hispida Leaf and Analysis of its Major Bioactive Polyphenols by HPLC
Anti-Inflammatory and Antioxidant Activity of Acalypha hispida Leaf and Analysis of its Major Bioactive Polyphenols by HPLC
- 26 May 2016
- Published by Springer Nature in Advances in Traditional Medicine
- Vol. 16 (2) , 147-152
Analgesic, anthelmintic and toxicity studies of Solanum violaceum Linn. Leaves
- 26 May 2016
- Published by Springer Nature in Advances in Traditional Medicine
- Vol. 16 (2) , 147-152
Analgesic, anthelmintic and toxicity studies of Solanum violaceum Linn. Leaves
- Open Access
- 30 May 2015
- Published by Springer Nature in Journal of Ethnobiology and Ethnomedicine
- Vol. 11 (1) , 44
Ethnomedicinal survey of various communities residing in Garo Hills of Durgapur, Bangladesh
Garo Hills represents one of earliest human habitation in Bangladesh preserving its ancient cultures due to the geographic location. It is situated in the most northern part of Durgapur sub-district having border with Meghalaya of India. Durgapur is rich in ethnic diversity with Garo and Hajong as the major ethnic groups along with Bangalee settlers from the mainstream population. Thus the ethnomedicinal practice in Garo Hills is considered rich as it encompasses three different groups. Present survey was undertaken to compile the medicinal plant usage among the various communities of the Garo Hills. The ethnomedicinal data was collected through open and focussed group discussions, and personal interviews using semi-structured questionnaire. A total of 185 people were interviewed, including the three community people and their traditional health practitioners (THPs). The usage of the plants were further analysed and are presented as use value (UV), informant consensus factor (ICF) and fidelity level (FL). A total of 71 plants from 46 families and 64 genera were documented during our survey. Gastrointestinal disorders represented the major ailment category with the use of 36 plant species followed by dermatological problems (25 species). The ICF ranged from 0.90 to 0.99, with an average value of 0.96. Leaves (41) were the principle source of medication followed by fruits (27). Trees (33) were the major plant type used in the ethnobotanical practice. A total of 25 plants showed high FL (70.91 to 100 %) with 12 plants showing maximum FL (100 %). A number of the plants appear to have unique ethnomedicinal uses. Present investigation revealed a rich traditional practice in the studied region, which provides primary health care to the local community. This compilation of the ethnobotanical knowledge can help researchers to identify the uses of various medicinal plants that have a long history of use.
- 30 May 2015
- Published by Springer Nature in Journal of Ethnobiology and Ethnomedicine
- Vol. 11 (1) , 44
Open AccessEthnomedicinal survey of various communities residing in Garo Hills of Durgapur, Bangladesh
Garo Hills represents one of earliest human habitation in Bangladesh preserving its ancient cultures due to the geographic location. It is situated in the most northern part of Durgapur sub-district having border with Meghalaya of India. Durgapur is rich in ethnic diversity with Garo and Hajong as the major ethnic groups along with Bangalee settlers from the mainstream population. Thus the ethnomedicinal practice in Garo Hills is considered rich as it encompasses three different groups. Present survey was undertaken to compile the medicinal plant usage among the various communities of the Garo Hills. The ethnomedicinal data was collected through open and focussed group discussions, and personal interviews using semi-structured questionnaire. A total of 185 people were interviewed, including the three community people and their traditional health practitioners (THPs). The usage of the plants were further analysed and are presented as use value (UV), informant consensus factor (ICF) and fidelity level (FL). A total of 71 plants from 46 families and 64 genera were documented during our survey. Gastrointestinal disorders represented the major ailment category with the use of 36 plant species followed by dermatological problems (25 species). The ICF ranged from 0.90 to 0.99, with an average value of 0.96. Leaves (41) were the principle source of medication followed by fruits (27). Trees (33) were the major plant type used in the ethnobotanical practice. A total of 25 plants showed high FL (70.91 to 100 %) with 12 plants showing maximum FL (100 %). A number of the plants appear to have unique ethnomedicinal uses. Present investigation revealed a rich traditional practice in the studied region, which provides primary health care to the local community. This compilation of the ethnobotanical knowledge can help researchers to identify the uses of various medicinal plants that have a long history of use.